Enhancing penile function: the impact of a regenerative multimodal protocol on erectile dysfunction.

Area of Science:

• Regenerative Medicine
• Urology
• Cardiovascular Health

Background:

• Erectile dysfunction (ED) affects quality of life and is linked to cardiovascular and metabolic issues.
• Conventional ED treatments like PDE5 inhibitors may fail in severe cases.
• Innovative therapeutic strategies are needed for refractory ED.

Purpose of the Study:

• To assess the efficacy and safety of a multimodal protocol for treating ED.
• The protocol included low-intensity shockwave therapy (LiST), umbilical cord-mesenchymal stem cell (UC-MSC) therapy, and hyperbaric oxygen therapy (HBOT).

Main Methods:

• Retrospective pragmatic observational study of 22 men with ED.
• Treatment involved a combination of LiST, intrapenile and intravenous UC-MSCs, and HBOT.
• Erectile function assessed using the Sexual Health Inventory for Men (SHIM) questionnaire pre- and post-treatment.

Main Results:

• Significant improvement in SHIM scores observed, with a mean increase of 3 points (p=0.0017).
• The multimodal protocol demonstrated a favorable safety profile.
• No major adverse events were reported during the follow-up period.

Conclusions:

• The combined therapy significantly enhanced erectile function in men with ED.
• The protocol presents a potentially viable and safe option for ED management.
• Further research via prospective randomized controlled trials is warranted to confirm these findings.